DeepHealth, a subsidiary of RadNet, has secured US FDA 510(k) clearance for its TechLive solution, a remote scanning system designed to centralise the operation and supervision of MR, CT, PET/CT, and ultrasound procedures.
The development comes at a time when the healthcare sector is grappling with a shortage of technical staff and rising wage pressures.
TechLive allows technologists to manage scans across multiple locations, thereby enhancing operational efficiency, extending the operating hours of centres, and improving access to intricate procedures.
Currently, over 300 RadNet systems, including MR, CT, PET/CT, and ultrasound, are integrated with TechLive.
This integration has led to increased patient throughput and improved quality by enabling real-time matching of expert staff with complex modalities.
In a pilot programme conducted at 64 RadNet facilities in the New York area, TechLive significantly reduced MRI room closure hours by 42% during the second quarter of 2025 compared to the same period in 2024. This reduction facilitated more timely scans for patients.
The pilot also demonstrated an increase in complex procedures, attributed to the involvement of remote experts.
Additionally, TechLive’s remote scanning capabilities extend to ultrasound, allowing senior sonographers and physicians to guide on-site technologists through complex cases, a modality that relies heavily on real-time operator expertise.
DeepHealth chief operating and technology officer Sham Sokka said: “TechLive represents a paradigm shift in how we approach imaging operations.
“By enabling real-time remote expertise, we are not only addressing today’s staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities.
“This FDA clearance validates DeepHealth’s vision of a connected imaging ecosystem that scales human expertise beyond physical boundaries.”
